Neuronetics, Inc. Increase (Decrease) in Accounts Receivable
Neuronetics, Inc. (STIM) reported Increase (Decrease) in Accounts Receivable of -$893.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-11
- Neuronetics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $115.00K.
- Neuronetics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$1.01M, a 138.37% decline year-over-year.
- Neuronetics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$2.16M.
- Neuronetics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$3.86M, a 713.17% decline year-over-year.
- Neuronetics, Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$3.54M, a 195.01% decline from fiscal 2024.
- Neuronetics, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $3.73M, a 57.80% decline from fiscal 2023.
- Neuronetics, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $8.83M, a 32.64% increase from fiscal 2022.
- Neuronetics, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $6.66M, a 74.43% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$893.00K 10-Q · filed 2026-08-11 | -$3.05M derived: sum of 3 quarters · filed 2026-08-11 | -$6.91M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | -$1.01M 10-Q · filed 2026-05-05 | -$3.17M derived: sum of 2 quarters · filed 2026-05-05 | -$7.03M derived: sum of 3 quarters · filed 2026-05-05 | -$7.18M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | -$2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$6.02M derived: sum of 2 quarters · filed 2026-03-17 | -$6.17M derived: sum of 3 quarters · filed 2026-08-11 | -$3.54M 10-K · filed 2026-03-17 | ||||
| 2025-09-30 | -$3.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$4.01M derived: sum of 2 quarters · filed 2026-08-11 | -$1.38M 10-Q · filed 2025-11-04 | -$1.49M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | -$148.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $2.48M 10-Q · filed 2026-08-11 | $2.37M derived: sum of 3 quarters · filed 2026-08-11 | $3.00M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $2.63M 10-Q · filed 2026-05-05 | $2.52M derived: sum of 2 quarters · filed 2026-05-05 | $3.15M derived: sum of 3 quarters · filed 2026-05-05 | $3.69M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $523.00K derived: sum of 2 quarters · filed 2026-03-17 | $1.06M derived: sum of 3 quarters · filed 2026-03-17 | $3.73M 10-K · filed 2026-03-17 | ||||
| 2024-09-30 | $630.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.17M derived: sum of 2 quarters · filed 2025-11-04 | $3.83M 10-Q · filed 2025-11-04 | $13.80M derived: sum of 4 quarters · filed 2026-03-17 | ||||
| 2024-06-30 | $537.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $3.20M 10-Q · filed 2025-08-05 | $13.17M derived: sum of 3 quarters · filed 2026-03-17 | $6.58M derived: sum of 4 quarters · filed 2026-03-17 | ||||
| 2024-03-31 | $2.67M 10-Q · filed 2025-05-06 | $12.63M derived: sum of 2 quarters · filed 2026-03-17 | $6.04M derived: sum of 3 quarters · filed 2026-03-17 | $9.16M derived: sum of 4 quarters · filed 2026-03-17 | ||||
| 2023-12-31 | $9.96M derived: 10-K 12 month − 8-K/A 9 month · filed 2026-03-17 | $3.38M derived: sum of 2 quarters · filed 2026-03-17 | $6.49M derived: sum of 3 quarters · filed 2026-03-17 | $8.83M 10-K · filed 2026-03-17 | ||||
| 2023-09-30 | -$6.59M derived: 8-K/A 9 month − 10-Q 6 month · filed 2025-02-06 | -$3.47M derived: sum of 2 quarters · filed 2025-02-06 | -$1.13M 8-K/A · filed 2025-02-06 | $7.93M 10-Q · filed 2023-11-07 | $941.13K derived: sum of 4 quarters · filed 2025-03-27 | |||
| 2023-06-30 | $3.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $5.46M 10-Q · filed 2024-08-12 | $7.53M derived: sum of 3 quarters · filed 2025-03-27 | $8.10M derived: sum of 4 quarters · filed 2025-03-27 | ||||
| 2023-03-31 | $2.34M 10-Q · filed 2024-05-07 | $2.01M 10-Q · filed 2023-05-15 | $4.41M derived: sum of 2 quarters · filed 2025-03-27 | $4.98M derived: sum of 3 quarters · filed 2025-03-27 | $8.45M derived: sum of 4 quarters · filed 2025-03-27 | |||
| 2022-12-31 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $2.65M derived: sum of 2 quarters · filed 2025-03-27 | $6.11M derived: sum of 3 quarters · filed 2025-03-27 | $6.66M 10-K · filed 2025-03-27 | $6.32M 10-K · filed 2023-03-07 | |||
| 2022-09-30 | $572.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $4.04M derived: sum of 2 quarters · filed 2023-11-07 | $4.58M 10-Q · filed 2023-11-07 | $4.26M 10-Q · filed 2022-11-08 | $5.30M derived: sum of 4 quarters · filed 2024-03-08 | |||
| 2022-06-30 | $3.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $4.01M 10-Q · filed 2023-08-08 | $3.69M 10-Q · filed 2022-08-02 | $4.73M derived: sum of 3 quarters · filed 2024-03-08 | $6.00M derived: sum of 4 quarters · filed 2024-03-08 | |||
| 2022-03-31 | $545.00K 10-Q · filed 2023-05-15 | $1.26M derived: sum of 2 quarters · filed 2024-03-08 | $2.53M derived: sum of 3 quarters · filed 2024-03-08 | $4.56M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2021-12-31 | $720.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $1.98M derived: sum of 2 quarters · filed 2024-03-08 | $4.02M derived: sum of 3 quarters · filed 2024-03-08 | $3.82M 10-K · filed 2024-03-08 | $3.05M 10-K · filed 2022-03-08 | |||
| 2021-09-30 | $1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $3.30M derived: sum of 2 quarters · filed 2022-11-08 | $3.10M 10-Q · filed 2022-11-08 | $4.70M derived: sum of 4 quarters · filed 2023-03-07 | ||||
| 2021-06-30 | $2.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $1.83M 10-Q · filed 2022-08-02 | $3.44M derived: sum of 3 quarters · filed 2023-03-07 | $2.37M derived: sum of 4 quarters · filed 2023-03-07 | ||||
| 2021-03-31 | -$202.00K 10-Q · filed 2022-05-12 | $1.40M derived: sum of 2 quarters · filed 2023-03-07 | $329.00K derived: sum of 3 quarters · filed 2023-03-07 | $778.00K derived: sum of 4 quarters · filed 2023-03-07 | ||||
| 2020-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $531.00K derived: sum of 2 quarters · filed 2023-03-07 | $980.00K derived: sum of 3 quarters · filed 2023-03-07 | $597.00K 10-K · filed 2023-03-07 | ||||
| 2020-09-30 | -$1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$622.00K derived: sum of 2 quarters · filed 2021-11-09 | -$1.00M 10-Q · filed 2021-11-09 | -$1.99M derived: sum of 4 quarters · filed 2022-03-08 | ||||
| 2020-06-30 | $449.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $66.00K 10-Q · filed 2021-08-03 | -$917.00K derived: sum of 3 quarters · filed 2022-03-08 | -$200.00K derived: sum of 4 quarters · filed 2022-03-08 | ||||
| 2020-03-31 | -$383.00K 10-Q · filed 2021-05-04 | -$1.37M derived: sum of 2 quarters · filed 2022-03-08 | -$649.00K derived: sum of 3 quarters · filed 2022-03-08 | $520.00K derived: sum of 4 quarters · filed 2022-03-08 | ||||
| 2019-12-31 | -$983.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$266.00K derived: sum of 2 quarters · filed 2022-03-08 | $903.00K derived: sum of 3 quarters · filed 2022-03-08 | $950.00K 10-K · filed 2022-03-08 | ||||
| 2019-09-30 | $717.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $1.89M derived: sum of 2 quarters · filed 2020-11-02 | $1.93M 10-Q · filed 2020-11-02 | $2.27M derived: sum of 4 quarters · filed 2021-03-02 | ||||
| 2019-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $1.22M 10-Q · filed 2020-08-04 | $1.55M derived: sum of 3 quarters · filed 2021-03-02 | $2.11M derived: sum of 4 quarters · filed 2021-03-02 | ||||
| 2019-03-31 | $47.00K 10-Q · filed 2020-05-05 | $384.00K derived: sum of 2 quarters · filed 2021-03-02 | $943.00K derived: sum of 3 quarters · filed 2021-03-02 | $1.39M derived: sum of 4 quarters · filed 2021-03-02 | ||||
| 2018-12-31 | $337.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $896.00K derived: sum of 2 quarters · filed 2021-03-02 | $1.34M derived: sum of 3 quarters · filed 2021-03-02 | $1.35M 10-K · filed 2021-03-02 | ||||
| 2018-09-30 | $559.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.00M derived: sum of 2 quarters · filed 2019-11-05 | $1.02M 10-Q · filed 2019-11-05 | $1.38M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-06-30 | $442.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $457.00K 10-Q · filed 2019-08-06 | $821.00K derived: sum of 3 quarters · filed 2020-03-03 | $1.18M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-03-31 | $15.00K 10-Q · filed 2019-05-07 | $379.00K derived: sum of 2 quarters · filed 2020-03-03 | $742.00K derived: sum of 3 quarters · filed 2020-03-03 | |||||
| 2017-12-31 | $364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $727.00K derived: sum of 2 quarters · filed 2020-03-03 | $690.00K 10-K · filed 2020-03-03 | |||||
| 2017-09-30 | $363.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $326.00K 10-Q · filed 2018-11-06 | ||||||
| 2017-06-30 | -$37.00K 10-Q · filed 2018-08-14 | |||||||
| 2016-12-31 | $123.00K 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |